Black Widow Spider Envenomation with Elevated Troponin I Levels

Year 2018, Volume: 9 Issue: 3, 55 - 57, 01.07.2018

Murat Daş Okhan Akdur Canan Akman Yasemin Çetinkaya

Abstract

Black Widow Spider Envenomation with Elevated Troponin I Levels

Abstract

Introduction: The black widow spider is found worldwide. Alpha-latrotoxin is responsible for the toxic effects related to the spider bite. We report the case of a patient who presented at the emergency department after being bitten by a black widow spider that later developed increased cardiac enzymes.Case Report: The patient was a 24-year-old male who had been bitten by a black spider inside his shoe while he was working in the garden. The patient was referred to the emergency department of department of emergency medicine Çanakkale Onsekiz Mart University Faculty of Training and Research Hospital with nausea, vomiting, and severe rigidity in the abdomen for the differential diagnosis of acute abdomen. With severe sweating, the patient had rales in the lower lung zones, and abdominal examination revealed diffuse abdominal guarding. Blood biochemistry revealed creatine kinase (CK): 1838 U/L, CKMb: 71.6 U/L, and troponin I: 0.14 ng/mL. In follow-ups, the troponin I levels increased to 3.01 ng/mL. Electrocardiography revealed normal sinus rhythm. He was followed with a bedside monitor for 3 days in the emergency department. When the patient’s troponin I and CK levels decreased, at the end of the third day he was discharged..Conclusion: Black widow envenomation should be followed for cardiac toxicity other than symptoms, such as muscle spasms, sweating, anxiety, and headache

Keywords

Black widow spider, troponin, envenomation

References

• Aaron Schneir, Richard F. Clark. Bites and Stings. In: Tintinalli JE, Stapc- zynski JS, Ma JO editors. Tintinalli’s emergency medicine a comprehen- sive study guide. 8nd ed. New York: McGraw-Hill; 2016. p. 1371-9.
• Sotelo Cruz N, Gómez Rivera N. Neurotoxic manifestations of black widow spider envenomation in paediatric patients. Neurologia 2016; 31: 215-22. [CrossRef]
• Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med 1992; 21: 782-7. [CrossRef]
• Camp NE. Black widow spider envenomation. J Emerg Nurs 2014; 40: 193-4. [CrossRef]
• Golcuk Y, Velibey Y, Gonullu H, Sahin M, Kocabas E. Acute toxic fulmi- nant myocarditis after a black widow spider envenomation: case report and literature review. Clin Toxicol (Phila) 2013; 51: 191-2. [CrossRef]
• Boyer LV, Binford GJ, Degan JA. Spider bites. In Auerbach PS, ed.: Wilder- ness medicine, 6th ed. Philadelphia: Elsevier; 2011: 993-5.
• Erdur B, Turkcuer I, Bukiran A, Kuru O, Varol I. Uncommon cardiovascular manifestations after Latrodectus bite. Am J Emerg Med 2007; 25: 232-5. [CrossRef]
• Kose A, Bozkurt S, Lok U, Zengmol M, Yildirim C, Gunay N, et al. Pre- sumptive Latrodectus bite with ileus and myocardial involvement. Wil- derness Environ Med 2010; 21: 271-2. [CrossRef]
• Levine M, Canning J, Chase R, Ruha AM. Cardiomyopathy following Lat- rodectus envenomation. West J Emerg Med 2010; 11: 521-3.
• Sari I, Zengin S, Davutoglu V, Yildirim C, Gunay N. Myocarditis after black widow spider envenomation. Am J Emerg Med 2008;26: 630.e1-3. [CrossRef]
• Bush SP, Davy JV. Troponin elevation after black widow spider enven- omation. CJEM 2015; 17: 571-5. [CrossRef]